Recruiting
Non-small cell lung cancer metastatic
RecruitingStudy on the Safety and Effects of STX-241 for Patients with Advanced Non-Small Cell Lung Cancer Resistant to EGFR Inhibitors
InvestigationalNo placebo
Study on the Safety and Effects of STX-241 for Patients with Advanced Non-Small Cell Lung Cancer Resistant to EGFR Inhibitors
InvestigationalNo placebo
- Disease:Non-small cell lung cancer metastatic
- Substances:Stx-241
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Stx-241



